MedPath
NMPA Approval

Pazufloxacin Mesilate Injection

国药准字H20061014

April 18, 2024

Drug Information

甲磺酸帕珠沙星注射液

宣搏

注射剂

2ml:0.1g(以C16H15FN2O4计)

化学药品

April 18, 2024

Company Information

Applicant Company

江西省南昌市南昌县小蓝工业园汇仁西大道758号

Manufacturing Company

江西省南昌市小蓝工业园汇仁西大道758号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲磺酸帕珠沙星注射液 - NMPA 批准文号 | MedPath